Latest News
Pharma improves reputation among German patient groups
A survey of 86 German patient groups suggests pharma’s reputation is improving in the country that has been wary of pharma in the past, with Amgen and Janssen leading the way.
More news
NHS Digital stops sharing patient data with immigration officials
Body will only share data in most serious criminal cases
MS patient advocate hopes for pharma engagement after award
Trishna Bharadia recognised for “tireless” campaigning
Alexion to file successor to rare diseases drug Soliris
New drug is in patient-friendly subcutaneous form
US patients and doctors happy to interact digitally – survey
Medics see digital health as a way to improve services and cut costs
Sanofi in talks with Evotec to out-licence antibiotic research
Evotec to collaborate with academia, pharma and biotech on new antimicrobials
ViiV’s HIV drug could be used for TB co-infection patients
Interim results suggest new treatment option for patients with TB and HIV
Novartis expands virtual clinical trial project with Science 37
Swiss pharma builds on existing collaboration with Science 37
Lack of test funding holding back precision medicine R&D
Precision medicine is becoming the norm in life sciences research but obstacles such as limited reimbursement for tests are hindering progress, according to a new survey.
Gilead takes ‘HIV eradication’ combo into clinic
New approach tackles reserve of HIV within the body
Amryt looking to expand rare disease franchise
Amryt looking to expand rare disease franchise
